Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

JOURNAL ARTICLE published September 2014 in The Lancet

Authors: Caroline Robert | Antoni Ribas | Jedd D Wolchok | F Stephen Hodi | Omid Hamid | Richard Kefford | Jeffrey S Weber | Anthony M Joshua | Wen-Jen Hwu | Tara C Gangadhar | Amita Patnaik | Roxana Dronca | Hassane Zarour | Richard W Joseph | Peter Boasberg | Bartosz Chmielowski | Christine Mateus | Michael A Postow | Kevin Gergich | Jeroen Elassaiss-Schaap | Xiaoyun Nicole Li | Robert Iannone | Scot W Ebbinghaus | S Peter Kang | Adil Daud